EUVIMEDEUVIMED entdecken
Open Access

Short and Long-term Body Weight Change Following the Switch to or the Addition of Integrase Inhibitors in Persons With HIV Differs by Sex

Cecile D Lahiri iD, C Christina Mehta, Qian Yang, Tsungirirai Maramba, Joffi Musonge-Effoe, Chin-An Yang, Julie B Dumond, Maria L Alcaide, Jordan E Lake iD, Leah H Rubin iD, Audrey L French, Jennifer Cocohoba und 12 weitere

Clinical Infectious Diseases · 17.03.2025 · 80 (3) · 575-584

DOI: 10.1093/cid/ciae474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 26.09.2024. Verfasst von Cecile D Lahiri und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: HIV Infections, HIV Integrase Inhibitors, Body Weight, Weight Gain. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMHD NIH HHS, NIDDK NIH HHS, NIAAA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sex-specific, long-term, body weight change in persons with human immunodeficiency virus (PWH) following switch to regimens containing integrase strand transfer inhibitors (INSTIs) is unknown.

Methods

We compared PWH enrolled in the MACS/WIHS Combined Cohort Study (2007–2020) who switched/added an INSTI to their antiretroviral therapy (ART) regimen to those remaining on non-INSTI ART and to people without human immunodeficiency virus (PWOH), by sex. Follow-up time was time since switch visit (or comparable visit in controls). Linear regression mixed-effects models assessed the effects of sex, group, and time upon weight and anthropometric measurements.

Results

Of 3464 participants included, women (411 INSTI, 709 non-INSTI, 818 PWOH) compared to men (223 INSTI, 412 non-INSTI, 891 PWOH) were younger (47.2 vs 54.5 years), were majority non-Hispanic Black (65% vs 23%), and had higher mean body mass index (31.5 vs 26.9 kg/m2), respectively. Women switching to INSTIs experienced greater absolute and percentage weight gain compared to men at 5 years: +3.0 kg (95% confidence interval [CI], 2.1–3.9) versus +1.8 kg (95% CI, .7–2.9) and +4.6% (95% CI, 3.5%–5.7%) versus +2.3% (95% CI, 1.0%–3.6%), respectively ([sex × time × group interaction, P < .01). Compared to men, women switching to INSTIs experienced greater hip and thigh circumference gain at 5 years: +2.6 cm (95% CI, 1.6–3.6) versus +1.2 cm (95% CI, .3–2.1) and +1.5 cm (95% CI, .7–2.2) versus −0.2 cm (95% CI, −.9 to .5), respectively.

Conclusions

Weight change among PWH over 5 years after switch to INSTI was 2-fold higher in women than men. The cardiometabolic implications of this difference in weight gain remain unknown.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV Integrase InhibitorsBody WeightWeight GainHumansMaleFemaleMiddle AgedAdultSex FactorsCohort StudiesBody Mass Index

Stichwörter der Autor:innen

HIVintegrase inhibitorssex differencesweight gain

Substanzen

HIV Integrase Inhibitors

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Laney Graduate School, Emory University, Atlanta, Georgia, USA.
  • Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Florida, USA.
  • Division of Infectious Diseases, Department of Internal Medicine, McGovern Medical School, UTHealth, Houston, Texas, USA.
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

ORCID-Profile: Cecile D Lahiri, Jordan E Lake, Leah H Rubin, Frank J Palella, Anandi N Sheth, Igho Ofotokun

Förderung

  • NIMHD NIH HHS
  • NIDDK NIH HHS
  • NIAAA NIH HHS
  • NHLBI NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • Office of AIDS Research
  • NIAID NIH HHS

Zitieren

APA

Lahiri, C. D., Mehta, C. C., Yang, Q., Maramba, T., Musonge-Effoe, J., Yang, C. A., Dumond, J. B., Alcaide, M. L., Lake, J. E., Rubin, L. H., French, A. L., Cocohoba, J., Kassaye, S. G., Sharma, A., Palella, F. J., Mellors, J., Konkle-Parker, D., Topper, E., Augenbraun, M., …, & Alvarez, J. A. (2025). Short and Long-term Body Weight Change Following the Switch to or the Addition of Integrase Inhibitors in Persons With HIV Differs by Sex. Clinical Infectious Diseases, 80(3), 575-584. https://doi.org/10.1093/cid/ciae474

Vancouver

Lahiri CD, Mehta CC, Yang Q, Maramba T, Musonge-Effoe J, Yang CA, et al. Short and Long-term Body Weight Change Following the Switch to or the Addition of Integrase Inhibitors in Persons With HIV Differs by Sex. Clinical Infectious Diseases. 2025;80(3):575-584. doi:10.1093/cid/ciae474

BibTeX
@article{Lahiri2025,
  author = {Lahiri, Cecile D and Mehta, C Christina and Yang, Qian and Maramba, Tsungirirai and Musonge-Effoe, Joffi and Yang, Chin-An and Dumond, Julie B and Alcaide, Maria L and Lake, Jordan E and Rubin, Leah H and French, Audrey L and Cocohoba, Jennifer and Kassaye, Seble G and Sharma, Anjali and Palella, Frank J and Mellors, John and Konkle-Parker, Deborah and Topper, Elizabeth and Augenbraun, Michael and Ali, Mohammed K and Sheth, Anandi N and Ziegler, Thomas R and Ofotokun, Igho and Alvarez, Jessica A},
  title = {Short and Long-term Body Weight Change Following the Switch to or the Addition of Integrase Inhibitors in Persons With HIV Differs by Sex},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  volume = {80},
  number = {3},
  pages = {575--584},
  doi = {10.1093/cid/ciae474}
}
Kostenlos starten →